1643 — Modern Chinese Medicine Co Cashflow Statement
0.000.00%
- HK$1.45bn
- HK$1.19bn
- CNY145.17m
Annual cashflow statement for Modern Chinese Medicine Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 114 | 124 | 68.3 | 14.8 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -0.788 | 5.44 | 0.385 | 9.42 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -58.6 | -9.67 | -66.7 | 25.5 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 57.6 | 126 | 8.48 | 59 | — |
| Capital Expenditures | -70.5 | -11.7 | -5.1 | -114 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.421 | 0.675 | 0.906 | -1.18 | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -70 | -11 | -4.19 | -115 | — |
| Financing Cash Flow Items | -26.7 | -0.014 | -0.005 | -0.001 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 116 | -8.73 | -0.326 | -0.144 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 103 | 106 | 4.01 | -56.6 | — |